Eco Animal Health Group PLC Market Authorisation in Indonesia (3609B)
30 January 2020 - 6:01PM
UK Regulatory
TIDMEAH
RNS Number : 3609B
Eco Animal Health Group PLC
30 January 2020
30 January 2020
ECO Animal Health Group plc
(the "Group")
(AIM: EAH)
Marketing Authorisation in Indonesia
ECO Animal Health Group plc, is pleased to announce that its
subsidiary ECO Animal Health Limited (ECO) has received a marketing
authorisation from the Ministry of Agriculture, Directorate General
of Livestock and Animal Health of the Republic of Indonesia. The
agreement is for the use of Aivlosin(R) water soluble granules in
chickens laying eggs for human consumption, with a zero day drug
withdrawal period for eggs. This approval has been granted under
the Group's other brand name Valosin(R).
Aivlosin(R) , ECO's patented antimicrobial, is used under
veterinary prescription for the treatment of a variety of
economically important respiratory and enteric (gut) diseases in
poultry and pigs.
Marc Loomes, CEO of ECO Animal Health Group plc, commented
"Indonesia is ranked the number one market in Southeast Asia, and
eighth globally, for laying bird numbers. Although the market is
currently somewhat fragmented, we expect this to change in the
future. It is key that the consumption of Aivlosin provides a zero
day drug withdrawal period for eggs which is a significant
competitive advantage for ECO. This latest approval demonstrates
ECO's continued progress in rolling out this indication for
commercial layers."
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contacts:
ECO Animal Health Group plc
Marc Loomes (CEO)
Christopher Wilks (CFO) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
N+1 Singer (Nominated Adviser & Joint
Broker)
Mark Taylor
Peter Steel
Alex Bond 020 7496 3000
Peel Hunt LLP (Joint Broker)
James Steel
Dr Christopher Golden 020 7418 8900
ECO Animal Health Group plc ("ECO" or "the Group") researches,
develops and commercialises products for livestock. Our business
strategy is to generate shareholder value by achieving the maximum
sales potential from the existing product portfolio whilst
investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
AGRSEEEFUESSEIF
(END) Dow Jones Newswires
January 30, 2020 02:01 ET (07:01 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024